Prof. Dr. Zahra Mohammed Adam Mohammed is a Professor in the Department of Pathology and Clinical Pathology at Omar Al-Mukhtar University, specializing in veterinary medicine with extensive expertise in pathology, tumor biology, and molecular medical microbiology. She earned her Ph.D. in Pathology from the University of Glasgow, focusing on the relationship between tumor and inflammation-related factors and patient survival in breast cancer, and holds an MSc in Molecular Medical Microbiology from the University of Nottingham, where she investigated genetic variability in hepatitis B virus. Her professional career encompasses progressive academic roles, including associate professorship, departmental leadership, and faculty scientific affairs, alongside postdoctoral research experience at the University of Glasgow. Dr. Mohammed has led and contributed to multiple research projects exploring tumor-host interactions, automated image analysis, and disease outcomes, with a strong emphasis on breast cancer and viral hepatitis. She has a distinguished publication record, high citation impact, and an h-index reflecting sustained scholarly influence. Her research techniques include immunohistochemistry, PCR, ELISA, histopathology, and automated scoring systems. Dr. Mohammed has also demonstrated leadership through editorial board service, research project management, and curriculum development. She has received multiple awards and honors for academic excellence, including distinctions for her BSc, a medal prize, and recognition for highly cited research. Her contributions to teaching, mentorship, and the advancement of veterinary pathology establish her as a leading figure in her field and a worthy candidate for prestigious recognition.
Profiles: Google Scholar | Scopus | ORCID
Featured Publications
1. Richards, C. H., Mohammed, Z., Qayyum, T., Horgan, P. G., & McMillan, D. C. (2011). The prognostic value of histological tumor necrosis in solid organ malignant disease: A systematic review. Future Oncology, 7(10), 1223–1235.
2. Mohammed, Z., Going, J. J., Edwards, J., Elsberger, B., Doughty, J. C., … (2012). The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. British Journal of Cancer, 107(5), 864–873.
3. Mohammed, Z. M. A., Going, J. J., Edwards, J., Elsberger, B., & McMillan, D. C. (2013). The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer. British Journal of Cancer, 109(6), 1676–1684.
4. Gujam, F. J. A., Edwards, J., Mohammed, Z. M. A., Going, J. J., & McMillan, D. C. (2014). The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer. British Journal of Cancer, 111(1), 157–165.
5. Gujam, F. J. A., Going, J. J., Edwards, J., Mohammed, Z. M. A., & McMillan, D. C. (2014). The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer. Critical Reviews in Oncology/Hematology, 89(2), 231–241.